As such, the parties point out that the Homescan data only indicates that of those panel members who bought at least one roll of Andrex, 43 % of their requirements were met by Andrex. More significantly, they state that the Homescan data does not provide answers to the following two questions:
(i)
How many panel members purchased at least one roll of Andrex (e.g. 1 000 or 7 000 out of the 8 000 UK households included in the Homescan panel)?
(ii)
Whether those that did purchase at least one roll of Andrex 'always` purchase Andrex (regardless of price) or only 'usually` or 'sometimes` purchase Andrex?